Roberta Patalano

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit

Donatella Paola Provvisiero, Mariarosaria Negri, Cristina de Angelis et al. · Scientific Reports · 2019 · 27 citations · Full text

The treatment with pasireotide in Cushing’s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center

Chiara Simeoli, Rosario Ferrigno, Maria Cristina De Martino et al. · Journal of Endocrinological Investigation · 2019 · 22 citations · Full text

An Innovative Approach to Designing Digital Health Solutions Addressing the Unmet Needs of Obese Patients in Europe

Roberta Patalano, Vincenzo De Luca, Jess Vogt et al. · International Journal of Environmental Research and Public Health · 2021 · 19 citations · Full text

World Health Organization, Digital Public Health, Unmet Needs +23

Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study

Claudia Pivonello, Panagoula Rousaki, Mariarosaria Negri et al. · Endocrine · 2016 · 17 citations

Oncology, Mtor Inhibitors, Somatostatin Analog +8

Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting

Claudia Pivonello, Roberta Patalano, Domenico Solari et al. · Endocrine · 2018 · 16 citations

Oncology, Pituitary Gland, Pan-pi3k Inhibitor +11